quick q for pgl holders, page-2

huntleys have a good report on AVX/PGL in last nights weekly report.

especially given you are an AVX shareholder it would be good reading for you. huntleys like the stock and say that every HIV drug candidate that has made it through phase 2 has gone through to market. they have a price target of 25cps...

having said all of this nice stuff they also liked it at 20cps, and 50cps+ in the past and at one time had a price prediction north of $2 i think.

given all the dilution and that AVX is going to end up having over a billion shares on issue i think those lofty predictions are all but gone.